India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
The approved product has an estimated market size of US$ 268 million for the twelve months ending June 2024, according to IQVIA
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
Reconfirms a relative bioavailability of 65 percent and significant savings when using DL-methionine
Subscribe To Our Newsletter & Stay Updated
